Scientific Advisory Group (SAG)

The NDEWS SAG is a combination of federal and nonfederal representatives from across the country with expertise in a multitude of fields. The SAG meetings and ongoing discussions provide a unique opportunity to create a new paradigm for identifying and understanding emerging drugs and drug trends. Coordinating Center staff, NIDA, and SAG members work together to build and shape each NDEWS component. The SAG meet virtually once a year to discuss important current and emerging drugs and drug issues and Coordinating Center staff consult with SAG members as needed for advice and guidance on various issues.

Caleb Banta-Green, PhD, MSW, MPH
Alcohol and Drug Abuse Institute
University of Washington

Michael Baumann, PhD
NIDA Intramural Research Program
Designer Drug Research Unit

Edward Boyer, MD, PhD
Brigham and Women’s Hospital

Fe Caces, PhD
Office of National Drug Control Policy

Robert Carlson, PhD
Center for Interventions, Treatment,
and Addictions Research
Wright State University

Tom Carr
Washington/Baltimore High Intensity
Drug Trafficking Area

Daniel Ciccarone, MD, MPH
University of California San Francisco

Linda Cottler, PhD, MPH
University of Florida
Department of Epidemiology

Robert DuPont, MD
Institute for Behavior and Health

Jim Hall
Ctr for Applied Research on Substance
Use and Health Disparities
Nova Southeastern University

Jennifer Havens, PhD, MPH
Center on Drug and Alcohol Research
Univ of Kentucky College of Medicine





Jill Head
DEA Emerging Trends
Program/Reference Materials Program
Special Testing & Research Laboratory

Brian Kelly, PhD
Purdue University

Jane Maxwell, PhD
University of Texas, Austin

LCDR Pedro A. Ortiz, PhD
Armed Forces Medical Examiner System
Division of Forensic Toxicology

Margaret Warner, Ph.D.
Centers for Disease Control and Prevention

Liqun Wong